Survival model results for brand new family ranging from mammographic density and you will exposure away from cancer of the breast death, stratified of the tumor services, AJCC level We–IV combined*
* Fully adjusted model includes covariates for AJCC stage (I, IIA, IIB, III, IV), registry (five sites), age at diagnosis (30–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, ?80 years), year of diagnosis (1996–1998, 1999–2001, 2002–2003, 2004–2005), body mass index (18.5 – <25, 25 – <30, ?30kg/m 2 ), mode of detection (screen-detected, interval-detected, other screen, clinically detected, other), surgery/radiation (no breast surgery, breast conserving therapy without radiation, breast conserving therapy with radiation, other surgery), chemotherapy (yes/no), and annual median income (<$42 000, $42 000 – <$52 000, $52 000 – <$66 000, ?$66 000). Women with missing covariate information were excluded. AJCC = American Joint Committee on Cancer; BI-RADS = Breast Imaging Reporting and Data System; CI = confidence interval; ER = estrogen receptor; HR = hazard ratio; PR = progesterone receptor.
† P-really worth regarding Wald statistic to check getting an overall total effectation of categorical BI-RADS thickness. All the mathematical testing had been two-sided.
N = 96 female omitted from bring about-particular models
007); specifically, elevated risk associated with having almost entirely fatty breasts was apparent for obese women (BMI ?30kg/m 2 , HR = 2.02, 95% CI = 1.37 to 2.97) but not overweight (BMI 25 – <30kg/m 2 , HR = 0.70, 95% CI = 0.40 to 1.23) or lean (BMI 18.5 – <25kg/m 2 , HR = 1.27, 95% CI = 0.74 to 2.17) women. To determine whether this association was being driven by a subgroup of women who were morbidly obese (BMI ?40kg/m 2 ), we conducted post hoc analyses after excluding 313 morbidly obese women, of whom 47 died of breast cancer. In BMI-stratified results, the elevated risk associated with having almost entirely fatty breasts remained apparent for obese women (BMI 30 – <40kg/m 2 , HR = 1.68, 95% CI = 1.07 to 2.63), and the interaction between breast density and BMI was still statistically significant (P = .01).
We found a statistically tall communication ranging from Bmi and you can BI-RADS density with respect to breast cancer passing (P to possess telecommunications =
* BI-RADS, Breast Imaging Revealing and you can Data System; Body mass index, bmi; CI, trust period; Time, hazard proportion. All the cancers: Bmi ? density telecommunications, P = .007.
† Fully adjusted model includes covariates for American Joint Committee on Cancer stage (I, IIA, IIB, III, IV), registry (five sites), age at diagnosis (30–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, ?80 years), year of diagnosis (1996–1998, 1999–2001, 2002–2003, 2004–2005), mode of detection (screen-detected, interval-detected, other screen, clinically detected, other), surgery/radiation (no breast surgery, breast conserving therapy without radiation, breast conserving therapy with radiation, other surgery), chemotherapy (yes/no), and annual median income (<$42 000, $42 000 – <$52 000, $52 000 – <$66 000, ?$66 000). Women with missing covariate information were excluded.
‡ P well crossdresser heaven worth from Wald figure to check to possess a complete effect out-of categorical BI-RADS density. All of the mathematical screening were a few-sided.
I discovered a statistically tall communication between Bmi and you can BI-RADS occurrence when it comes to cancer of the breast dying (P to possess interaction =
* BI-RADS, Nipple Imaging Revealing and you will Studies Program; Bmi, bmi; CI, rely on period; Time, danger ratio. Most of the cancers: Bmi ? occurrence interaction, P = .007.
† Fully adjusted model includes covariates for American Joint Committee on Cancer stage (I, IIA, IIB, III, IV), registry (five sites), age at diagnosis (30–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–79, ?80 years), year of diagnosis (1996–1998, 1999–2001, 2002–2003, 2004–2005), mode of detection (screen-detected, interval-detected, other screen, clinically detected, other), surgery/radiation (no breast surgery, breast conserving therapy without radiation, breast conserving therapy with radiation, other surgery), chemotherapy (yes/no), and annual median income (<$42 000, $42 000 – <$52 000, $52 000 – <$66 000, ?$66 000). Women with missing covariate information were excluded.